Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,252 | 307 | 97.7% |
| Education | $122.91 | 3 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $466.36 | 32 | $0 (2024) |
| Incyte Corporation | $417.71 | 36 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $406.18 | 25 | $0 (2024) |
| Daiichi Sankyo Inc. | $344.55 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $343.93 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $272.71 | 16 | $0 (2024) |
| Astellas Pharma US Inc | $257.59 | 12 | $0 (2024) |
| GENZYME CORPORATION | $224.56 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $198.13 | 9 | $0 (2024) |
| G1 Therapeutics, Inc. | $170.37 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,174 | 118 | Astellas Pharma US Inc ($212.63) |
| 2023 | $1,775 | 101 | Janssen Biotech, Inc. ($193.95) |
| 2022 | $1,399 | 89 | Bayer HealthCare Pharmaceuticals Inc. ($158.04) |
| 2021 | $27.24 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($27.24) |
All Payment Transactions
310 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $16.30 | General |
| Category: Hematology/Oncology | ||||||
| 11/12/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $14.92 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: HEMATOLOGY | ||||||
| 11/04/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $22.15 | General |
| Category: Hematology | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: CELLT | ||||||
| 10/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Oncology | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $21.92 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | VPRIV (Biological) | Food and Beverage | In-kind items and services | $34.25 | General |
| Category: GENETIC DISEASE | ||||||
| 10/02/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $13.34 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 242 | 269 | $35,156 | $15,569 |
| 2022 | 2 | 94 | 103 | $14,476 | $6,857 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 163 | 187 | $24,684 | $10,682 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 39 | 40 | $5,280 | $2,350 | 44.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 17 | $2,992 | $1,508 | 50.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 25 | $2,200 | $1,028 | 46.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 83 | $10,956 | $5,108 | 46.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 20 | $3,520 | $1,750 | 49.7% |
About Cameron Dennis, FNP
Cameron Dennis, FNP is a Family healthcare provider based in Laurel, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2022. The National Provider Identifier (NPI) number assigned to this provider is 1922756196.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cameron Dennis, FNP has received a total of $5,375 in payments from pharmaceutical and medical device companies, with $2,174 received in 2024. These payments were reported across 310 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($5,252).
As a Medicare-enrolled provider, Dennis has provided services to 336 Medicare beneficiaries, totaling 372 services with total Medicare billing of $22,427. Data is available for 2 years (2022–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Laurel, MS
- Active Since 03/16/2022
- Last Updated 03/17/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1922756196
Products in Payments
- KEYTRUDA (Biological) $235.27
- Stivarga (Drug) $221.63
- JAKAFI (Drug) $217.07
- SARCLISA (Biological) $202.54
- MONJUVI (Drug) $200.64
- COSELA (Drug) $184.75
- Nubeqa (Drug) $184.55
- REBLOZYL (Biological) $170.59
- DARZALEX (Biological) $155.10
- Enhertu (Drug) $149.99
- OPDIVO (Biological) $144.83
- ENHERTU (Biological) $141.21
- MEKINIST (Drug) $122.92
- Rezlidhia (Drug) $118.75
- Udenyca (Biological) $114.18
- TECVAYLI (Biological) $111.27
- PLUVICTO (Drug) $108.61
- ENHERTU (Drug) $102.83
- XPOVIO (Drug) $101.68
- LONSURF (Drug) $101.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Laurel
Lori Howell, Fnp, FNP
Family — Payments: $7,459
Tiffany Hilbun, Fnp, FNP
Family — Payments: $7,295
Mrs. Lauren Aycock, Fnp, FNP
Family — Payments: $6,310
Ashlynn Bennett
Family — Payments: $6,034
Brittany Gardner, Fnp-C, FNP-C
Family — Payments: $5,378
Illisia Johnston, Np-C, NP-C
Family — Payments: $5,218